NCT05880277 (POCUS) is a NA clinical trial of POCUS in Patellofemoral Disorder, sponsored by Youngstown State University.

Who is sponsoring NCT05880277?

NCT05880277 is sponsored by Youngstown State University.

What drugs are being tested in NCT05880277?

Interventions in NCT05880277: POCUS.

What condition does NCT05880277 study?

NCT05880277 studies Patellofemoral Disorder.

Is NCT05880277 still recruiting?

NCT05880277 is currently status unknown. Last updated 30 May 2023.

Last reviewed 2023-05-30 · How we verify

NCT05880277: POCUS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Diagnostic POCUS of Patellar Tendinopathy in Female Athletes

Status unknown NA Last updated 30 May 2023

What this trial tests

NA trial testing POCUS in Patellofemoral Disorder in 20 participants. Status unknown.

Timeline

17 February 2023

Primary endpoint
15 May 2024

15 May 2025

Quick facts

Lead sponsor	Youngstown State University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	20
Start date	17 February 2023
Primary completion	15 May 2024
Estimated completion	15 May 2025
Sites	1 location across United States

Drugs / interventions tested

POCUS

Conditions studied

Patellofemoral Disorder — all drugs for Patellofemoral Disorder →

Sponsor

Youngstown State University

Who can join

Adults 18 to 25, female only, with Patellofemoral Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Purpose: The purpose of this study is to determine the clinical effectiveness of point-of-care diagnostic ultrasound in the assessment of patellar tendon pathologies

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of POCUS

Trials testing the same drug.

NCT07286643 — Echocardiography-guided Cirrhosis and Liver Failure-Intensive Care Protocol Sepsis · NA · recruiting
NCT05602077 — Accuracy of Sonography in Elbow Trauma · NA · completed
NCT07046793 — Fracture Ultrasound in Kids Wirst Trial (FRUSKI-Wrist) · completed
NCT05423847 — Triage UltraSound in Tb Endemic Regions · completed

Other Youngstown State University trials

Trials by the same sponsor.

NCT07528742 — Vagus Nerve Stimulation for Reaction Time · NA · recruiting
NCT06549998 — High-Fidelity Patient Simulation on Clinical Reasoning Skills and Interprofessional Competencies · NA · completed
NCT06545539 — Does Participation in a Fall Preparedness Program Improve Fall Efficacy Among Older Adults · NA · not yet recruiting
NCT05908045 — Have Physical Therapists Attitudes and Beliefs Towards Vital Assessment Changed Following the COVID-19 Pandemic? · unknown
NCT05915039 — Computer Assisted Learning (CAL) Module Use for Re-training of Blood Pressure Measurements by Physical Therapy Students · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05880277 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Youngstown State University
Last refreshed: 30 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05880277.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing